Adagene (ADAG) Total Current Liabilities (2019 - 2025)
Adagene's (ADAG) quarterly Total Current Liabilities came in at $25172.1 billion in Q4 2025, down 34.08% year-on-year from $38184.9 billion in Q4 2024, and up 88272715.97% on a QoQ basis from $28.5 million in Q2 2025.
Adagene (ADAG) Total Current Liabilities (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Total Current Liabilities data on file, last reported at $25172.1 billion in Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 34.08% year-over-year to $25172.1 billion in Q4 2025; TTM through Dec 2025 was $25172.1 billion, a 34.08% decrease from a year earlier, with the FY2025 full-year figure at $25172.1 billion, down 34.08% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $25172.1 billion, up from $28.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for ADAG reached as high as $56455.1 billion in Q2 2022 and fell as low as $28.5 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $24534.0 billion across 5 years, with a median of $28313.9 billion in 2023.
- Across the five-year window, Total Current Liabilities jumped 190877015.16% in 2022 and tumbled 100.0% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $29.8 million in 2021, then soared by 184697642.74% to $55080.4 billion in 2022, then slumped by 42.89% to $31455.6 billion in 2023, then advanced by 21.39% to $38184.9 billion in 2024, then tumbled by 34.08% to $25172.1 billion in 2025.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $25172.1 billion in Q4 2025, $28.5 million in Q2 2025, and $38184.9 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - | 25,172.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25,172.10 Bn |
| Jun 30, 2025 | 28.52 Mn |
| Dec 31, 2024 | 38,184.94 Bn |
| Jun 30, 2024 | 39.52 Mn |
| Dec 31, 2023 | 31,455.65 Bn |
| Jun 30, 2023 | 38,991.62 Bn |
| Dec 31, 2022 | 55,080.40 Bn |
| Jun 30, 2022 | 56,455.10 Bn |
| Dec 31, 2021 | 29.82 Mn |
| Jun 30, 2021 | 29.58 Mn |
| Dec 31, 2020 | 16.15 Mn |
| Dec 31, 2019 | 7.18 Mn |